AI Assistant
Blog
Pricing
Log In
Sign Up
Orally administrated risedronate can commit V.GAMMA.2V.DELTA.2 T cells to IFN-.GAMMA. secreting effectors in patients with osteoporosis
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
